Original Publication Date: 1 January, 2015
Publication / Source: Future Oncology
Authors: Rishi Wagle, Masahisa Ohtsuka, Hui Ling & Martin Pichler
Over the last decade, the field of cancer therapy and the mode of action of approved cancer drugs have dramatically changed across the globe. The struggle against cancer in clinical trials shifted from the testing of cytotoxic ‘classical’ chemotherapeutic drugs toward agents with clearly defined molecular targets .